Objective: To describe the screening for uterine cancer by
visual methods. Method: We conducted a prospective and descriptive study over a period of 12 months from January
to December 2020. Direct observation of providers and interview of patients were performed for data collection. Results: Out of 3400 patients, 1024 were enrolled for the study, or 30.11%. The average age of the patients was 41 years with
the extremes of 17 to 87 years. Women aged 40 to 45 were the most represented
with 58.78%, (n = 602). Housewives 85.83% (n = 879), they had a primary
education level in 71.09% of cases (n = 728), the vast majority were married
92.28% (n = 945). Multiparous represented 58.78% (n = 602) of the sample,
nulliparous 18.26% (n = 187), women living in rural areas 30.17% (n = 309), in
urban areas 69.82% (n = 715). The test was positive in 43 patients (4.19%) but squamocylindrical junction was not visible in
17% of cases. The preparation of acetic acid and lugol: good preparation in 100% of cases; the conditions of use are not respected in 27% for acetic acid and 38%
for lugol. Conclusion: Routine
screening for cervical cancer (SCC) by visual methods is essential to decrease
the incidence of invasive cervical cancer.
References
[1]
Ferley, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M. (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base Number 10 [Internet]. http://globocan.iarc.fr
[2]
Delvenne, P., Jacobs, N., Dean and Kridelka, K. (2003) Cervical Cancer Screening in Belgium: Update in 2003. Rev. med. Cork, 58, 316-318.
[3]
Bayo, S., Parkin, D.M., Koumare, A.K., Diallo, A.N., Ba, T., Soumaré, S. and Sangaré, S. (1990) Cancer in Mali, 1987-1988. International Journal of Cancer, 45, 679-684.
https://doi.org/10.1002/ijc.2910450418
[4]
Atreche, L. (2008) Pap Smears and Precancerous Lesions through Laboratory Experience of Pathological Anatomy of CHU HASSAN II of FES Concerning 2,359 Cases of FCV of 2004 to 2007. Thesis of Med, 2726.
[5]
Pointreaua, Y., Ruffier Loubière, A., Denis, F. and Barillota, I. (2010) Cervical Cancer. Cancer/Radiotherapy, 14, S147-S153.
https://doi.org/10.1016/S1278-3218(10)70018-4
[6]
(2010) High Authority of Health. In: Recommendations in Public Health: Inventory and Recommendations for Cervical Cancer Screening in France. HAS, Paris, 1-256.
[7]
Bernard, E., Saint-Lary, O., Haboubi, L. and Le Breton, J. (2013) Uterine Cancer Screening: Knowledge and Participation of Women. Santé Publique, 25, 255-262.
https://www.cairn.info/revue-sante-publique-2013-3-page-255.htm
[8]
Sancho-Garnier, H. (2005) Les problèmes de dépistage du cancer du col dans les différents pays. In: Le dépistage du cancer du col de l’utérus. Dépistage et cancer, Springer, Paris.
[9]
Winer, R.L., Hughes, J.P., Feng, Q., O’Reilly, S., Kiviat, N.B., Holmes, K.K., et al. (2006) Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women. The New England Journal of Medicine, 354, 2645-2654.
https://doi.org/10.1056/NEJMoa053284
[10]
Boulanger, J.C., Sevestre, H., Bauville, E., Ghighi, C., Harlicot, J.P. and Gondry, J. (2004) Epidemiology of HPV Infection. Gynécologie Obstétrique & Fertilité, 32, 218-223. https://doi.org/10.1016/j.gyobfe.2004.01.013
[11]
Chee, C.C., Begassat, M. and Kovess, V. (2005) Factors Associated with Cervical Cancer Screening in a Mutualist Population. Revue d'Epidémiologie et de Santé Publique, 53, 69-75. https://doi.org/10.1016/S0398-7620(05)84573-0
[12]
Edith, M. (2015) Benefit of Visual Inspection with Acetic Acid and Lugol Solute with Colposcope in Screening for Cervical Lesions in Gabon. Pan African Medical Journal, 22, 165.
[13]
Bakali, G.K. (2012) Place of Visual Inspection with Acetic Acid in Cervical Cancer Screening at about 740 Cases at Souisse Maternity in Rabat.
